Antinociceptive interaction of (±)-CPP and propentofylline in monoarthritic rats
Author
dc.contributor.author
Morales, Francisco
Author
dc.contributor.author
Constandil, Luis
Author
dc.contributor.author
Pelissier Serrano, Teresa
Author
dc.contributor.author
Hernández, Alejandro
Author
dc.contributor.author
Laurido, Claudio
Admission date
dc.date.accessioned
2019-03-11T13:19:35Z
Available date
dc.date.available
2019-03-11T13:19:35Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Arthritis Research and Therapy, Volumen 14, Issue 4, 2018,
Identifier
dc.identifier.issn
14786354
Identifier
dc.identifier.issn
14786362
Identifier
dc.identifier.other
10.1186/ar4030
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165667
Abstract
dc.description.abstract
Introduction: Multiple studies have shown that glial cells of the spinal cord, such as astrocytes and microglia, have close contact with neurons, suggesting the term tripartite synapse. In these synapses, astrocytes surrounding neurons contribute to neuronal excitability and synaptic transmission, thereby increasing nociception and thus the persistence of chronic pain. Conversely, the N-methyl-D-aspartate (NMDA) receptor is crucial in the generation and maintenance of chronic pain. It has multiple sites of modulation. One is the site of recognition of extracellular neurotransmitter (glutamate), which can be blocked by competitive antagonists such as (3-(2-carboxipiperazin-4)1-propyl phosphonic acid), (±)-CPP, resulting in a blockade of the calcium current and thus the intracellular transduction process. In the present study, we investigated whether the potential antinociceptive effect of glial inhibition produced by propentofylline (PPF) can be enhanced when combined with an NMDA-recep